- Home
- SST vs VRCA Comparison
SST vs VRCA Comparison
Compare SST & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- VRCA
- Stock Information
- Founded
- SST 2013
- VRCA 2013
- Country
- SST United States
- VRCA United States
- Employees
- SST N/A
- VRCA N/A
- Industry
- SST Diversified Commercial Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- VRCA Health Care
- Exchange
- SST Nasdaq
- VRCA Nasdaq
- Market Cap
- SST 57.3M
- VRCA 58.7M
- IPO Year
- SST N/A
- VRCA 2018
- Fundamental
- Price
- SST $8.43
- VRCA $4.68
- Analyst Decision
- SST Strong Buy
- VRCA Hold
- Analyst Count
- SST 1
- VRCA 5
- Target Price
- SST $10.00
- VRCA $60.00
- AVG Volume (30 Days)
- SST 51.0K
- VRCA 39.3K
- Earning Date
- SST 11-06-2025
- VRCA 11-03-2025
- Dividend Yield
- SST N/A
- VRCA N/A
- EPS Growth
- SST N/A
- VRCA N/A
- EPS
- SST N/A
- VRCA N/A
- Revenue
- SST $317,055,000.00
- VRCA $14,704,000.00
- Revenue This Year
- SST N/A
- VRCA $332.45
- Revenue Next Year
- SST $12.20
- VRCA $12.85
- P/E Ratio
- SST N/A
- VRCA N/A
- Revenue Growth
- SST N/A
- VRCA 5.72
- 52 Week Low
- SST $2.90
- VRCA $3.82
- 52 Week High
- SST $15.00
- VRCA $20.13
- Technical
- Relative Strength Index (RSI)
- SST 61.63
- VRCA 36.32
- Support Level
- SST $7.51
- VRCA $4.35
- Resistance Level
- SST $9.00
- VRCA $5.23
- Average True Range (ATR)
- SST 0.59
- VRCA 0.34
- MACD
- SST 0.08
- VRCA -0.04
- Stochastic Oscillator
- SST 75.97
- VRCA 23.25
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.